Paid Clinical Trials in Ann Arbor, MI
As of July 2026, 978 paid clinical trials are recruiting in Ann Arbor, Michigan. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Ann Arbor offers studies at sites including University of Michigan for conditions such as Advanced Solid Tumor, Obesity, Prostate Cancer, Colorectal Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Ann Arbor
Trials by drug in Ann Arbor
Filter results
Newly added in Ann Arbor
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
The Bottle Optimization Testing Tiny Little Eaters Study
Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Artificial Intelligence (AI) for Proximal Caries Detection and Its Impact on Treatment Threshold
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
885 clinical trials
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
Assessment of CCM in HF With Higher Ejection Fraction
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
Top Research Study Locations in Ann Arbor
Researchers run research studies in Ann Arbor, MI at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Michigan | Colorectal Cancer, Healthy, Acute Kidney Injury | 399 |
| University of Michigan Rogel Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Hematopoietic and Lymphatic System Neoplasm | 81 |
| Trinity Health Saint Joseph Mercy Hospital Ann Arbor | Stage IV Lung Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Acute Myeloid Leukemia | 66 |
| C S Mott Children's Hospital | B Acute Lymphoblastic Leukemia, Neuroblastoma, Recurrent Malignant Solid Neoplasm | 32 |
| University of Michigan Comprehensive Cancer Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Carcinoma | 28 |
| University of Michigan Health System | Chronic Kidney Disease, ADA SCID, Adolescent Congenital Heart Disease | 23 |
| VA Ann Arbor Healthcare System, Ann Arbor, MI | Prostate Cancer, Adult Growth Hormone Deficiency, Alcohol Use Disorder | 23 |
| C.S. Mott Children's Hospital | Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Anaplastic Astrocytoma | 18 |
| University of Michigan Hospital | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 15 |
| University of Michigan Medical Center | Liver Transplant, Cutaneous Melanoma, Stage II, Glomerulosclerosis, Focal Segmental | 9 |
| University of Michigan Health | Aortic Stenosis, Breast Reconstruction, Colorectal Adenoma | 8 |
| University of Michigan School of Dentistry | Gum Disease, Healing Wound, Dental Diseases | 8 |
| Michigan Medicine | Sleep Apnea, Obstructive, Aging, Alzheimer Disease | 7 |
| University of Michigan Hospitals | Propionic Acidemia, Adenoid Cystic Carcinoma, Chromophobe Renal Cell Carcinoma | 7 |
| Trinity Health IHA - Obstetrics and Gynecology West Arbor | Ampulla of Vater Carcinoma, Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 6 |
| University of Michigan Kellogg Eye Center | Cone Rod Dystrophy, Juvenile Macular Degeneration, Stargardt Disease | 6 |
| University of Michigan, Michigan Medicine | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation | 6 |
| CS Mott Children's Hospital | Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Advanced Solid Tumor | 4 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Multiple Myeloma, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis | 4 |
| Saint Joseph Mercy Hospital | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Castration Levels of Testosterone | 4 |
| The University of Michigan | Down Syndrome, Hypertonia, Muscle, Nasal Airway Obstruction | 4 |
| VA Ann Arbor Healthcare System | Cardiovascular Diseases, Castrate-sensitive, Castrate-sensitive Prostate Cancer | 4 |
| University of Michigan Health System - Ann Arbor | Asthma, Plasma Cell Myeloma Refractory, Autoimmune Haemolytic Anaemia | 4 |
| C.S Mott Children's Hospital | Neuroblastoma | 3 |
| Michigan Med University of Michigan | ANCA Associated Vasculitis (AAV), Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
Active & Upcoming Studies in Ann Arbor (2026)
Recruiting trials in Ann Arbor grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (287 active studies)
- Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome · Phase 1 · University of Michigan Rogel Cancer Center
- Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial · University of Michigan Rogel Cancer Center
Neurology & pain (77 active studies)
Cardiovascular (56 active studies)
- Precision T1D Platform - New Therapies for Cardio-Renal Complications · Phase 2 · Oregon Health and Science University
- CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA) · VA Office of Research and Development
Diabetes & metabolic (27 active studies)
- Precision T1D Platform - New Therapies for Cardio-Renal Complications · Phase 2 · Oregon Health and Science University
- Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Mental health & behavior (22 active studies)
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
- Intern Health Study 2026 · University of Michigan
Pediatric (15 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study · Carelon Research
Eye & vision (10 active studies)
- Study of Serine Supplementation to Protect Vision in MacTel · Phase 3 · The Lowy Medical Research Institute Limited
- A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults · Astellas Pharma Global Development, Inc.
HIV / STI (5 active studies)
- A Self-administered PrEP Decisional Aid for Dissemination With HIV Self-test Kits (DASH) · University of Michigan
- National Liver Cancer Screening Trial · Phase 4 · University of Texas Southwestern Medical Center
Vaccines (4 active studies)
- A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised · Phase 3 · Pfizer
- KIDney Injury in Times of COVID-19 (KIDCOV) · University of California, San Francisco
Common conditions studied in Ann Arbor
- Advanced Solid Tumor (10 active studies)
- Obesity (10 active studies)
- Prostate Cancer (10 active studies)
- Colorectal Cancer (9 active studies)
- Malignant Solid Neoplasm (9 active studies)
- Stroke (9 active studies)
Leading research sponsors in Ann Arbor
- University of Michigan
- University of Michigan Rogel Cancer Center
- National Cancer Institute (NCI)
- VA Office of Research and Development
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Ann Arbor?
There are approximately 978 recruiting clinical trials in Ann Arbor, Michigan listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Ann Arbor pay participants?
Most recruiting trials in Ann Arbor compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Ann Arbor?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Ann Arbor?
The most common conditions under active study in Ann Arbor include Advanced Solid Tumor (10), Obesity (10), Prostate Cancer (10), Colorectal Cancer (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Ann Arbor?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Ann Arbor on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Ann Arbor?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Ann Arbor?
Recruiting research sites in Ann Arbor include University of Michigan, University of Michigan Rogel Cancer Center, Trinity Health Saint Joseph Mercy Hospital Ann Arbor, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Ann Arbor right now?
The largest active categories in Ann Arbor are Cancer & tumors (287), Neurology & pain (77), Cardiovascular (56). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.